January 22, 2019
James Nathanielsz, CEO of Propanc Biopharma, talks about preclinical development, funding, cancer stem cells and more.
October 25, 2017
Propanc Biopharma submitted a request for an orphan drug designation with the US Food and Drug Administration (FDA) for PRP.
October 19, 2017
Propanc Biopharma announced its key scientific data was published in a peer-reviewed journal showing.
September 27, 2017
Propanc Biopharma shared the results of recent scientific experiments showing PRP with a potential effectiveness of a clinical approach for...
August 30, 2017
Propanc Biopharma provided an update on the starting stages of their First-In-Human study towards the full-scale manufacture of the investigational...
July 20, 2017
Propanc Biopharma announced it received notification of acceptance for its lead patent application from the Chinese Patent Office.
July 18, 2017
Propanc Biopharma established a four-year joint research partnership with the Jaén University in Spain to expand the company's product pipeline.